Pediatric bloodstream infections in Cambodia, 2007 to 2011

Nicole Stoesser1, Catrin E Moore, Joanna M Pocock

  • 1Angkor Hospital for Children, Siem Reap, Cambodia. nicole.stoesser@ndm.ox.ac.uk

Insights

Pediatric bacterial bloodstream infections (BSIs) are common in Cambodia, with significant mortality. Salmonella Typhi and Staphylococcus aureus were leading causes, and antimicrobial resistance is a concern.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Pediatric bacterial bloodstream infections (BSIs) contribute significantly to global child morbidity and mortality.
  • Limited epidemiological data exists for resource-limited regions like Southeast Asia, impacting public health strategies.

Purpose of the Study:

  • To investigate the epidemiology and antimicrobial susceptibility of BSIs in children in Siem Reap, Cambodia.
  • To analyze demographic, clinical, and outcome data associated with pediatric BSIs.

Main Methods:

  • Retrospective analysis of blood cultures from pediatric patients between 2007 and 2011.
  • Identification of bacterial pathogens and assessment of antimicrobial susceptibility patterns.

Main Results:

  • A BSI incidence of 7.9% was observed, with an increasing trend over the study period.
  • Common pathogens included Salmonella Typhi (22.8%), Staphylococcus aureus (12.2%), and Streptococcus pneumoniae (10.0%).
  • High mortality (19.0%) was noted, particularly in neonates (36.9%), and associated with meningitis and Klebsiella pneumoniae.

Conclusions:

  • BSI poses a significant health challenge in Cambodian children, associated with substantial mortality.
  • Further research is required to understand neonatal sepsis, atypical organisms, and pneumococcal disease epidemiology for vaccine strategies.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...